FDA warned Wise Women’s Choice that its natural birth control cream is an unapproved new drug sold with pregnancy-prevention claims.
What happened
FDA reviewed the product’s labeling, website, and Facebook group as of May 2023 and found the cream offered for sale in the U.S. with claims that it immobilizes sperm and prevents pregnancy. FDA said the product is a drug and a new drug without an approved application. FDA also noted a 2021 warning letter to Smart Women’s Choice for similar claims and that the website says the product is marketed with that doctor’s permission and backing.
What FDA found
The product is a drug because its labeling says it affects the human body by immobilizing sperm and preventing fertilization.
FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)The product is a new drug because it is not generally recognized as safe and effective for its labeled contraceptive uses.
FD&C Act section 201(p), 21 U.S.C. 321(p)The product is an unapproved new drug because no FDA-approved application is in effect for it.
FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)Selling or shipping the product in interstate commerce is prohibited without an approved application.
FD&C Act sections 301(d) and 505(a), 21 U.S.C. 331(d) and 355(a)
What FDA wants
Notify FDA in writing within fifteen working days of receipt of this letter of the specific steps you have taken to address any violations, including an explanation of each step to prevent recurrence and copies of related documentation. If you cannot complete corrective actions within fifteen working days, state the reason for the delay and the time within which you will complete the correction.
Who should pay attention
- companies selling contraceptive products online
- distributors and retailers of vaginal creams
- firms making pregnancy-prevention claims in labeling or social media
This is a summary. Read the original letter on fda.gov.